The Impact of the Tax Cuts and Jobs Act on the Life Science Sector

February 16, 2018

The Tax Cuts and Jobs Act (TCJA), which was signed into law on December 22, 2017, is of particular interest to the life science investment community. Described as a windfall for corporate tax infrastructure and the most far-reaching piece of tax legislation enacted in the United States (US) since the Tax Reform Act of 1986, the TCJA highlights the potential for US companies to repatriate their liquid foreign subsidiaries at a lower tax rate.

Xcenda's latest issue brief, "Life Science Investing During the US Tax Reform Windfall: Key Insights to Guide Smart Decision Making," takes a look at the mergers and acquisition activity in the life science sector as result of the act and provides key insights for investing in the sector.

Click here to download the issue brief.